Comparison between Revascularization and Optimal Medical Therapy in Patients with Stable Angina Pectoris

  • سال انتشار: 1395
  • محل انتشار: مجله علوم پزشکی ایران، دوره: 4، شماره: 2
  • کد COI اختصاصی: JR_JHES-4-2_008
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 155
دانلود فایل این مقاله

نویسندگان

Maryam Nabati

Mazandaran University of Medical Sciences, Sari, Iran

Ehsan Vazirian

Mazandaran University of Medical Sciences, Sari, Iran

Ali Ghaemian

Mazandaran University of Medical Sciences, Sari, Iran

Jamshid Yazdani

Mazandaran University of Medical Sciences, Sari, Iran

Maryam Hosseinzadeh

Mazandaran University of Medical Sciences, Sari, Iran

چکیده

Background and Purpose: Regarding usefulness of revascularization versus optimal medical therapy in patients with stable angina pectoris, data are challenging. The aim of this ۱۲-month follow-up study was to compare the survival benefit associated with revascularization versus optimal medical therapy on the patients with stable angina pectoris. Materials and Methods: A prospective clinical study was conducted on ۱۸۱ patients with stable angina pectoris or an evidence of myocardial ischemia that underwent coronary arteriography. Patients with left main or left main equivalent were excluded from our study. Of these patients, ۵۷ received full medical therapy alone, ۷۹ were assigned to the percutaneous coronary intervention (PCI) and ۴۵ to the coronary artery bypass graft (CABG) group. The patients were compared for primary outcomes including cardiac death and non-fatal myocardial infarction and secondary outcomes including disabling angina by chi-square and Fisher’s exact test. Results: After ۱۲ months, cardiac death occurred in ۸.۸% of patients in the medical group and ۰.۰% of patients in the PCI and CABG group. This was statistically significant (P = ۰.۰۰۴). Disabling angina occurred in ۲۳.۱% of patients in the medical group, ۱۷.۷% of patients in the PCI group, and ۱۵.۵% of patients in CABG group (P = ۰.۳۴۹). Cerebrovascular accident occurred in ۱.۹% of patients in the medical group, ۱.۳% of patients in the PCI group, and ۶.۷% of patients in CABG group (P = ۰.۱۶۷). These were not statistically significant. Conclusion: Revascularization compared with the optimal medical therapy may be a better strategy in reducing cardiovascular mortality in patients with stable angina pectoris and suitable coronary anatomy.

کلیدواژه ها

Coronary Disease, Prognosis, Revascularization, Everolimus, Stent

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.